Roche, wielding new implant data, looks beyond Lucentis for wet AMD FDA turns back DBV Technologies’ peanut allergy patch, raising questions about its design Teva's ProAir Digihaler breezes into U.S. market Armed with FDA nod, Otsuka unit Astex preps to launch oral chemotherapy Inqovi Honeywell adds COVID vaccine-ready vials to its new line of glass alternatives Featured Story | By Fraiser Kansteiner Roche's Genentech is eyeing a simpler option for neovascular age-related macular degeneration treatment. Its Port Delivery System—an eye implant that continuously dispenses ranibizumab—has passed muster against Lucentis in a phase 3 nAMD study. If approved, the device would allow wet AMD patients to cut down treatment visits to two per year. read more |
| |
|---|
|
Top Stories By Conor Hale The FDA has turned down DBV Technologies’ peanut allergy patch treatment for children, Viaskin Peanut, raising questions about the patch's design and performance. It's the latest turn in a long, winding path toward approval for the would-be allergy therapy. read more By Fraiser Kansteiner Teva's ProAir Digihaler snagged FDA approval at the tail end of 2018. Now, the smart inhaler-companion app combo has made its U.S. debut—the first of three Digihaler products the Israeli pharma aims to launch stateside before year-end. ProAir Digihaler tracks patient data, offers guidance on inhaler technique and can even transmit event data to doctors. read more By Fraiser Kansteiner For nearly two decades, blood cancer patients have depended upon time-consuming infusions of the chemotherapy decitabine. Now, with an FDA approval for Astex Pharmaceuticals' oral version, they have an alternative. read more By Fraiser Kansteiner The glass used to make vials for vaccines and other medications is scarce, and with the looming need to store and distribute COVID-19 shots on a massive scale, Honeywell aims to step in with a new line of plastic alternatives dubbed Aclar Edge. read more | | Get insights on key considerations for a successful tech transfer for manufacturing a drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. Download this Catalent Biologics eBook. |
Enrollment Showcase | Presented by: Biotility Taught by experienced professionals, Biotility’s online short courses provide the knowledge and practical skills valued by the bioscience industry. Enhance your career through coursework in one of our certificate pathways, including Document Management, Operations Management, and Quality Management. Learn more. |
| |
|---|
|
Resources Sponsored by: Paysign Download the whitepaper for a solution designed to connect manufacturers, pharmacists, and patients. In this special guide, you will learn not just about the law but about the portal platform designed to change the entire process for all. Sponsored by: Catalent In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. Sponsored by: Phlow Corp. Interested in putting patients, people, and planet over profit in a fast-paced environment? Please Apply: VP of Integrated Supply Chain and VP of Manufacturing, Science, & Technology Sponsored by: Lonza Pharma & Biotech A novel spray-dried dispersion platform has been developed to faciliate high drug load applications Sponsored by: PRA Health Sciences Collaboration across the industry will be key to meeting the demands of the RACE Act and ensuring pediatric patients receive the care and treatments they need. Sponsored by: InterSystems Accurate, timely insights are everything. Whatever the question, the answers demand real world data you can trust. Healthy data advances reliable insights, and takes the error out of AI. Healthy data is not just useable, but invaluable. Healthy data starts with InterSystems. |
